Riede, Tiffany

Public records identify Ralph R. Riede and Marilyn Tiffany as the principals behind the family office in Englewood, Colorado. The entity appears in SEC filings where one or both are listed as beneficial owners of equity stakes, indicating direct control over portfolio decisions. No external investment committee or professional management layer is publicly documented.

The office's sourcing model is opaque by design. Given the absence of a public website, LinkedIn presence, or institutional marketing, deal flow likely originates through the principals' personal networks, corporate relationships tied to the underlying family businesses, or direct outreach to micro-cap public companies conducting private placements. There is no evidence of intermediary-driven or agent-sourced transactions.

No. The entity has never registered as an investment adviser, does not market to external limited partners, and fulfills the structural definition of a single-family office under SEC rules. All known capital is internal family money, and the office does not appear on any institutional allocator database or capital introduction platform.

Based on available public records, the office's confirmed activity is limited to public equity positions, often in small-cap or international companies. The firm's most notable disclosed position was in Global Pharm Holdings Group, a China-based pharmaceutical distributor. No private equity, venture capital, real estate, or fixed-income holdings have been publicly tied to the entity, though undisclosed private investments may exist.

The specific source of the family's wealth has not been publicly disclosed. The principals' low public profile and the office's non-commercial structure suggest wealth likely originated from private operating businesses, professional practices, or generational family assets rather than a widely reported liquidity event. No records link the office to a specific founding company or industry.